Table 1.
Physiologic measurements during topical application of adrenaline at baseline
| MAP (mm Hg) |
HR (beats/min) |
pH | PaCO2 (mm Hg) |
PaO2 (mm Hg) |
BE (mmol/L) |
Glucose (mg/dL) |
|
|---|---|---|---|---|---|---|---|
| A Control | 96 ± 12 | 299 ± 43 | 7.44 ± 0.07 | 39.1 ± 4.8 | 215 ± 30 | 2.6 ± 3.0 | 145 ± 22 |
| A 10–9 mol/L | 95 ± 6 | 281 ± 33 | 7.43 ± 0.05 | 36.6 ± 3.6 | 206 ± 25 | 0.3 ± 2.9 | 136 ± 15 |
| A 10–7 mol/L | 99 ± 6 | 265 ± 32 | 7.40 ± 0.05 | 39.1 ± 5.1 | 204 ± 28 | 0.9 ± 3.2 | 132 ± 19 |
| A 10–5 mol/L | 100 ± 13 | 286 ± 26 | 7.43 ± 0.05 | 39.2 ± 3.6 | 202 ± 21 | 2.1 ± 2.8 | 133 ± 22 |
| A 10–4 mol/L | 98 ± 9 | 289 ± 28 | 7.42 ± 0.03 | 38.9 ± 2.0 | 201 ± 28 | 1.1 ± 3.1 | 138 ± 28 |
| V Control | 95 ± 4 | 306 ± 39 | 7.44 ± 0.03 | 37.3 ± 2.7 | 202 ± 24 | 1.9 ± 3.0 | 145 ± 16 |
| V 10–11 mol/L | 96 ± 5 | 308 ± 46 | 7.43 ± 0.05 | 39.5 ± 4.1 | 214 ± 24 | 2.0 ± 2.5 | 151 ± 9 |
| V 10–9 mol/L | 94 ± 4 | 282 ± 53 | 7.44 ± 0.04 | 38.2 ± 4.3 | 216 ± 26 | 1.7 ± 2.5 | 135 ± 13 |
| V 10–7 mol/L | 92 ± 7 | 298 ± 48 | 7.45 ± 0.03 | 37.8 ± 4.1 | 204 ± 31 | 2.4 ± 1.1 | 135 ± 17 |
| V 10–6 mol/L | 89 ± 15 | 285 ± 49 | 7.43 ± 0.03 | 39.8 ± 3.1 | 203 ± 42 | 1.8 ± 1.6 | 136 ± 18 |
Values are mean ± SD
MAP Mean arterial blood pressure, HR Heart rate, BE Base excess, PaCO2 Partial pressure of carbon dioxide, PaO2 Partial pressure of oxygen, A adrenaline, V Vasopressin